- Sustainability
- DE&I
- Pandemic
- Finance
- Legal
- Technology
- Regulatory
- Global
- Pricing
- Strategy
- R&D/Clinical Trials
- Opinion
- Executive Roundtable
- Sales & Marketing
- Executive Profiles
- Leadership
- Market Access
- Patient Engagement
- Supply Chain
- Industry Trends
PAREXEL Introduces Integrated Medical Writing Solutions Service Offering
PAREXEL International Corporation introduced PAREXEL's Medical Writing Solutions, a new offering that provides several communication services needed throughout each critical stage of the drug development and commercialization process.
The medical writing solutions team is made up of hundreds of trained experts that develop high quality documents which are compliant with the latest regulations and guidelines in order to drive value for clients.
The offering is currently available as both functional service projects or as part of larger strategic partnerships based on their study needs. For more information visit http://www.parexel.com/medicalwriting.
What Every Pharma CEO Should Know About Unlocking the Potential of Scientific Data
December 11th 2024When integrated into pharmaceutical enterprises, scientific data has the potential to drive organizational growth and innovation. Mikael Hagstroem, CEO at leading laboratory informatics provider LabVantage Solutions, discusses how technology partners add significant value to pharmaceutical R&D, in addition to manufacturing quality.
Key Findings of the NIAGARA and HIMALAYA Trials
November 8th 2024In this episode of the Pharmaceutical Executive podcast, Shubh Goel, head of immuno-oncology, gastrointestinal tumors, US oncology business unit, AstraZeneca, discusses the findings of the NIAGARA trial in bladder cancer and the significance of the five-year overall survival data from the HIMALAYA trial, particularly the long-term efficacy of the STRIDE regimen for unresectable liver cancer.
